PsyBio Therapeutics Corp.
PSYBF
$0.00
$0.000.00%
OTC PK
| 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | 06/30/2022 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 12.40K | 69.00K | 800.00 | 180.60K | 911.80K |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 93.50K | 103.20K | 89.10K | 150.40K | 167.30K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | 29.30K | 163.40K | -- | -- |
| Total Current Assets | 105.90K | 201.40K | 253.30K | 331.00K | 1.08M |
|
|
|||||
| Total Current Assets | 105.90K | 201.40K | 253.30K | 331.00K | 1.08M |
| Net Property, Plant & Equipment | 167.60K | 88.70K | 126.70K | 164.80K | 202.80K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 9.70K | 9.70K | 10.30K | 10.90K | 11.60K |
| Total Assets | 283.10K | 299.80K | 390.40K | 506.70K | 1.29M |
|
|
|||||
| Total Accounts Payable | -- | 860.20K | 907.00K | 559.10K | 448.20K |
| Total Accrued Expenses | 1.39M | 512.20K | 425.30K | 58.30K | 57.90K |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 96.10K | 96.10K | 135.50K | 158.00K | 152.10K |
| Total Finance Division Other Current Liabilities | 488.50K | 488.50K | 513.50K | 525.00K | 550.00K |
| Total Other Current Liabilities | 488.50K | 488.50K | 513.50K | 525.00K | 550.00K |
| Total Current Liabilities | 1.97M | 1.96M | 1.98M | 1.30M | 1.21M |
|
|
|||||
| Total Current Liabilities | 1.97M | 1.96M | 1.98M | 1.30M | 1.21M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | 14.10K | 55.70K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 1.97M | 1.96M | 1.98M | 1.31M | 1.26M |
|
|
|||||
| Common Stock & APIC | 17.71M | 17.46M | 16.88M | 16.88M | 16.88M |
| Retained Earnings | -22.87M | -22.62M | -21.80M | -20.86M | -19.94M |
| Treasury Stock & Other | 3.48M | 3.50M | 3.33M | 3.17M | 3.09M |
| Total Common Equity | -1.69M | -1.66M | -1.59M | -807.90K | 29.60K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -1.69M | -1.66M | -1.59M | -807.90K | 29.60K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -1.69M | -1.66M | -1.59M | -807.90K | 29.60K |
|
|
|||||